rosiglitazone, an agonist of ppar, inhibits non-small cell carcinoma cell proliferation in part through activation of tumor sclerosis complex-2罗格列酮,ppar激动剂,抑制非小细胞癌肿瘤细胞增殖通过激活硬化complex-2.pdfVIP

Hindawi Publishing Corporation PPAR Research Volume 2007, Article ID 29632, 8 pages doi:10.1155/2007/29632 Research Article Rosiglitazone, an Agonist of PPARγ, Inhibits Non-Small Cell Carcinoma Cell Proliferation In Part through Activation of Tumor Sclerosis Complex-2 ShouWei Han,1, 2 Ying Zheng,1, 2 and Jesse Roman1, 3 1 Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Emory University School of Medicine, Emory University, Atlanta, GA 30322, USA 2 Department of Obstetrics and Gynecology, West China 2nd U